Cargando…

Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden

OBJECTIVE: We assessed eating disorder (ED) illness status, symptomatology, treatment access, anxiety, and depression in the first year of the COVID‐19 pandemic among individuals with a pre‐existing ED in the United States (US), the Netherlands (NL), and Sweden (SE). METHODS: Participants completed...

Descripción completa

Detalles Bibliográficos
Autores principales: Termorshuizen, Jet D., Sun, Quan, Borg, Stina, Mantilla, Emma F., Goode, Rachel W., Peat, Christine M., Thornton, Laura M., Watson, Hunna, van Furth, Eric F., Birgegård, Andreas, Bulik, Cynthia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851943/
https://www.ncbi.nlm.nih.gov/pubmed/36237128
http://dx.doi.org/10.1002/eat.23824
_version_ 1784872518963691520
author Termorshuizen, Jet D.
Sun, Quan
Borg, Stina
Mantilla, Emma F.
Goode, Rachel W.
Peat, Christine M.
Thornton, Laura M.
Watson, Hunna
van Furth, Eric F.
Birgegård, Andreas
Bulik, Cynthia M.
author_facet Termorshuizen, Jet D.
Sun, Quan
Borg, Stina
Mantilla, Emma F.
Goode, Rachel W.
Peat, Christine M.
Thornton, Laura M.
Watson, Hunna
van Furth, Eric F.
Birgegård, Andreas
Bulik, Cynthia M.
author_sort Termorshuizen, Jet D.
collection PubMed
description OBJECTIVE: We assessed eating disorder (ED) illness status, symptomatology, treatment access, anxiety, and depression in the first year of the COVID‐19 pandemic among individuals with a pre‐existing ED in the United States (US), the Netherlands (NL), and Sweden (SE). METHODS: Participants completed online surveys in April–July 2020, at the early stage of the pandemic, and one year later. At one‐year follow‐up, we added questions addressing retrospective changes in ED symptoms, treatment, and anxiety/depression since the start of the COVID‐19 pandemic. We present descriptive statistics and assess change in ED symptomatology, treatment, and anxiety/depression among those with an active or lingering ED. RESULTS: Participants (US n = 132; NL n = 219; SE n = 702) were mostly young and female with a history of anorexia nervosa (>60% in all three countries). Across countries, respondents reported impact of COVID‐19 on ED symptoms at both time points, with improvement in US and NL at one‐year follow‐up, and stable but less impact on ED symptoms in SE. Furthermore, at one‐year follow‐up, roughly half of those in treatment reported reduced treatment access and quality, and the majority of the sample reported increased anxiety and depressive mood since the start of the pandemic. DISCUSSION: Our findings suggest that the self‐perceived impact of COVID‐19 changed over time but remained concerning even one year after the start of the pandemic. Clinicians, community organizations, and policy makers are encouraged to address potentially changing treatment needs in the face of public health emergency events. PUBLIC SIGNIFICANCE: Our findings suggest that the impact of COVID‐19 on individuals with eating disorders decreased over time but remained concerning even one year after the start of the pandemic and that the impact differed across countries. Clinicians, community organizations, and policy makers are encouraged to incorporate this knowledge to address potentially changing treatment needs in the face of public health emergency events.
format Online
Article
Text
id pubmed-9851943
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98519432023-01-25 Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden Termorshuizen, Jet D. Sun, Quan Borg, Stina Mantilla, Emma F. Goode, Rachel W. Peat, Christine M. Thornton, Laura M. Watson, Hunna van Furth, Eric F. Birgegård, Andreas Bulik, Cynthia M. Int J Eat Disord Original Articles OBJECTIVE: We assessed eating disorder (ED) illness status, symptomatology, treatment access, anxiety, and depression in the first year of the COVID‐19 pandemic among individuals with a pre‐existing ED in the United States (US), the Netherlands (NL), and Sweden (SE). METHODS: Participants completed online surveys in April–July 2020, at the early stage of the pandemic, and one year later. At one‐year follow‐up, we added questions addressing retrospective changes in ED symptoms, treatment, and anxiety/depression since the start of the COVID‐19 pandemic. We present descriptive statistics and assess change in ED symptomatology, treatment, and anxiety/depression among those with an active or lingering ED. RESULTS: Participants (US n = 132; NL n = 219; SE n = 702) were mostly young and female with a history of anorexia nervosa (>60% in all three countries). Across countries, respondents reported impact of COVID‐19 on ED symptoms at both time points, with improvement in US and NL at one‐year follow‐up, and stable but less impact on ED symptoms in SE. Furthermore, at one‐year follow‐up, roughly half of those in treatment reported reduced treatment access and quality, and the majority of the sample reported increased anxiety and depressive mood since the start of the pandemic. DISCUSSION: Our findings suggest that the self‐perceived impact of COVID‐19 changed over time but remained concerning even one year after the start of the pandemic. Clinicians, community organizations, and policy makers are encouraged to address potentially changing treatment needs in the face of public health emergency events. PUBLIC SIGNIFICANCE: Our findings suggest that the impact of COVID‐19 on individuals with eating disorders decreased over time but remained concerning even one year after the start of the pandemic and that the impact differed across countries. Clinicians, community organizations, and policy makers are encouraged to incorporate this knowledge to address potentially changing treatment needs in the face of public health emergency events. John Wiley & Sons, Inc. 2022-10-13 2023-01 /pmc/articles/PMC9851943/ /pubmed/36237128 http://dx.doi.org/10.1002/eat.23824 Text en © 2022 The Authors. International Journal of Eating Disorders published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Termorshuizen, Jet D.
Sun, Quan
Borg, Stina
Mantilla, Emma F.
Goode, Rachel W.
Peat, Christine M.
Thornton, Laura M.
Watson, Hunna
van Furth, Eric F.
Birgegård, Andreas
Bulik, Cynthia M.
Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden
title Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden
title_full Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden
title_fullStr Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden
title_full_unstemmed Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden
title_short Longer‐term impact of COVID‐19 among individuals with self‐reported eating disorders in the United States, the Netherlands, and Sweden
title_sort longer‐term impact of covid‐19 among individuals with self‐reported eating disorders in the united states, the netherlands, and sweden
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851943/
https://www.ncbi.nlm.nih.gov/pubmed/36237128
http://dx.doi.org/10.1002/eat.23824
work_keys_str_mv AT termorshuizenjetd longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT sunquan longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT borgstina longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT mantillaemmaf longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT gooderachelw longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT peatchristinem longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT thorntonlauram longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT watsonhunna longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT vanfurthericf longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT birgegardandreas longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden
AT bulikcynthiam longertermimpactofcovid19amongindividualswithselfreportedeatingdisordersintheunitedstatesthenetherlandsandsweden